• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险对比解读中的细微差别。

Subtleties in the interpretation of hazard contrasts.

作者信息

Martinussen Torben, Vansteelandt Stijn, Andersen Per Kragh

机构信息

Section of Biostatistics, University of Copenhagen, Øster Farimagsgade 5B, 1014, Copenhagen K, Denmark.

Department of Applied Mathematics, Computer Sciences and Statistics, Ghent University, Krijgslaan 281 (S9), 9000, Gent, Belgium.

出版信息

Lifetime Data Anal. 2020 Oct;26(4):833-855. doi: 10.1007/s10985-020-09501-5. Epub 2020 Jul 11.

DOI:10.1007/s10985-020-09501-5
PMID:32654089
Abstract

The hazard ratio is one of the most commonly reported measures of treatment effect in randomised trials, yet the source of much misinterpretation. This point was made clear by Hernán (Epidemiology (Cambridge, Mass) 21(1):13-15, 2010) in a commentary, which emphasised that the hazard ratio contrasts populations of treated and untreated individuals who survived a given period of time, populations that will typically fail to be comparable-even in a randomised trial-as a result of different pressures or intensities acting on different populations. The commentary has been very influential, but also a source of surprise and confusion. In this note, we aim to provide more insight into the subtle interpretation of hazard ratios and differences, by investigating in particular what can be learned about a treatment effect from the hazard ratio becoming 1 (or the hazard difference 0) after a certain period of time. We further define a hazard ratio that has a causal interpretation and study its relationship to the Cox hazard ratio, and we also define a causal hazard difference. These quantities are of theoretical interest only, however, since they rely on assumptions that cannot be empirically evaluated. Throughout, we will focus on the analysis of randomised experiments.

摘要

风险比是随机试验中最常报告的治疗效果衡量指标之一,但也是诸多误解的根源。埃尔南在一篇评论文章(《流行病学》(马萨诸塞州剑桥)21(1):13 - 15,2010年)中明确指出了这一点,该评论强调风险比对比的是在给定时间段内存活的治疗组和未治疗组个体群体,由于不同群体受到不同压力或强度的影响,这些群体通常无法进行比较——即使在随机试验中也是如此。这篇评论极具影响力,但也引发了惊讶与困惑。在本笔记中,我们旨在通过特别研究在一段时间后风险比变为1(或风险差为0)时能从治疗效果中学到什么,从而更深入地洞察风险比及差异的微妙解释。我们进一步定义了一个具有因果解释的风险比,并研究其与考克斯风险比的关系,还定义了因果风险差。然而,这些量仅具有理论意义,因为它们依赖于无法通过实证评估的假设。自始至终,我们将专注于随机试验的分析。

相似文献

1
Subtleties in the interpretation of hazard contrasts.风险对比解读中的细微差别。
Lifetime Data Anal. 2020 Oct;26(4):833-855. doi: 10.1007/s10985-020-09501-5. Epub 2020 Jul 11.
2
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.在存在不依从性的随机试验中评估安全性上限的因果推断方法。
Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.
3
The built-in selection bias of hazard ratios formalized using structural causal models.使用结构因果模型形式化的风险比的内在选择偏差。
Lifetime Data Anal. 2024 Apr;30(2):404-438. doi: 10.1007/s10985-024-09617-y. Epub 2024 Feb 15.
4
The hazard ratio as a measure of effect in clinical trials of elderly populations: common pitfalls and misconceptions.作为评估老年人群临床试验效果的指标,危害比:常见的陷阱和误解。
Aging Clin Exp Res. 2021 Mar;33(3):505-511. doi: 10.1007/s40520-020-01538-8. Epub 2020 Apr 8.
5
Bias of the additive hazard model in the presence of causal effect heterogeneity.存在因果效应异质性时相加风险模型的偏差。
Lifetime Data Anal. 2024 Apr;30(2):383-403. doi: 10.1007/s10985-024-09616-z. Epub 2024 Mar 11.
6
Learning the Treatment Impact on Time-to-Event Outcomes: The Transcarotid Artery Revascularization Simulated Cohort.学习对事件时间结局治疗影响:经颈动脉血运重建模拟队列。
Int J Environ Res Public Health. 2022 Sep 30;19(19):12476. doi: 10.3390/ijerph191912476.
7
Causal interpretation of the hazard ratio in randomized clinical trials.随机临床试验中风险比的因果解释。
Clin Trials. 2024 Oct;21(5):623-635. doi: 10.1177/17407745241243308. Epub 2024 Apr 28.
8
The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?平均风险比——当比例风险假设不成立时,用于事件发生时间终点的良好效应量度?
Methods Inf Med. 2018 May;57(3):89-100. doi: 10.3414/ME17-01-0058. Epub 2018 May 2.
9
Introducing a new estimator and test for the weighted all-cause hazard ratio.引入一种新的加权全因风险比估计量和检验方法。
BMC Med Res Methodol. 2019 Jun 11;19(1):118. doi: 10.1186/s12874-019-0765-1.
10
Doubly Robust Additive Hazards Models to Estimate Effects of a Continuous Exposure on Survival.双重稳健加性风险模型估计连续暴露对生存的影响。
Epidemiology. 2017 Nov;28(6):771-779. doi: 10.1097/EDE.0000000000000742.

引用本文的文献

1
Correcting for bias due to mismeasured exposure in mediation analysis with a survival outcome.在生存结局的中介分析中校正因暴露测量错误导致的偏倚。
J R Stat Soc Ser C Appl Stat. 2025 Feb 14;74(4):969-993. doi: 10.1093/jrsssc/qlaf010. eCollection 2025 Nov.
2
Hazards Constitute Key Quantities for Analyzing, Interpreting and Understanding Time-to-Event Data.风险因素是分析、解释和理解事件发生时间数据的关键量。
Biom J. 2025 Jun;67(3):e70057. doi: 10.1002/bimj.70057.
3
Measuring the Performance of Survival Models to Personalize Treatment Choices.
评估生存模型的性能以实现个性化治疗选择。
Stat Med. 2025 Mar 30;44(7):e70050. doi: 10.1002/sim.70050.
4
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional Hazards.非比例风险下随机对照试验中事件发生时间分析的统计方法比较
Stat Med. 2025 Feb 28;44(5):e70019. doi: 10.1002/sim.70019.
5
Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma.使用参数模型和Royston-Parmar模型对生存结局进行无锚定模拟治疗比较,并应用于乐伐替尼联合帕博利珠单抗治疗肾细胞癌。
BMC Med Res Methodol. 2025 Jan 30;25(1):26. doi: 10.1186/s12874-025-02480-x.
6
Multiplicative versus additive modelling of causal effects using instrumental variables for survival outcomes - a comparison.使用工具变量对生存结局进行因果效应的乘法建模与加法建模——一项比较
Stat Methods Med Res. 2025 Jan;34(1):3-25. doi: 10.1177/09622802241293765. Epub 2024 Dec 10.
7
Long-term exposure to air pollution, greenness and temperature and survival after a nonfatal myocardial infarction.长期暴露于空气污染、绿化水平与温度与非致死性心肌梗死存活后。
Environ Pollut. 2024 Aug 15;355:124236. doi: 10.1016/j.envpol.2024.124236. Epub 2024 May 25.
8
Reply to Heitjan's commentary.对海特扬评论的回复。
Clin Trials. 2024 Oct;21(5):638-639. doi: 10.1177/17407745241243311. Epub 2024 Apr 28.
9
Causal interpretation of the hazard ratio in randomized clinical trials.随机临床试验中风险比的因果解释。
Clin Trials. 2024 Oct;21(5):623-635. doi: 10.1177/17407745241243308. Epub 2024 Apr 28.
10
Methods for non-proportional hazards in clinical trials: A systematic review.临床试验中非比例风险方法:系统评价。
Stat Methods Med Res. 2024 Jun;33(6):1069-1092. doi: 10.1177/09622802241242325. Epub 2024 Apr 9.